Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2012
Business Overview: The Company operates outpatient physical and occupational therapy clinics, managing facilities for third parties and providing physician services. As of June 30, 2012, the Company operated 419 clinics in 42 states. The Company primarily operates through subsidiary clinic partnerships where it holds a majority interest, with non-controlling interests typically held by managing therapists.
Key Financial Metrics
| Metric (in thousands, except per share) | Six Months Ended June 30, 2012 | Six Months Ended June 30, 2011 | Three Months Ended June 30, 2012 | Three Months Ended June 30, 2011 |
|---|---|---|---|---|
| Net Revenues | $126,541 | $116,653 | $63,959 | $59,912 |
| Net Income (Common Shareholders) | $9,327 | $8,646 | $4,849 | $4,900 |
| Diluted EPS | $0.79 | $0.72 | $0.41 | $0.41 |
| Operating Cash Flow | $18,967 | $12,841 | N/A | N/A |
| Cash and Equivalents (End of Period) | $8,811 | $8,992 | $8,811 | $8,992 |
| Total Debt (Notes + Revolver) | $20,884 | $24,217 | $20,884 | $24,217 |
| Revolving Credit Facility Outstanding | $20,000 | $23,500 | $20,000 | $23,500 |
| Goodwill | $99,141 | $92,750 | $99,141 | $92,750 |
Margins (Six Months 2012 vs 2011):
- Gross Margin: 26.2% vs 27.5%
- Operating Margin: 16.2% vs 16.8%
- Net Margin (Common): 7.4% vs 7.4%
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 8.5% for the six months ended June 30, 2012, driven by a 10.4% increase in total patient visits (1.17 million vs 1.06 million). This growth was partially offset by a $2.1 million decrease in "other revenues" due to reduced physician services revenue.
- Profitability: Net income attributable to common shareholders increased 7.9% year-over-year for the six-month period. However, for the three-month period, net income decreased slightly by 1.0% ($4.85M vs $4.90M).
- Cost Structure: Clinic operating costs as a percentage of net revenues increased to 73.8% for the six months (from 72.5% in 2011). The provision for doubtful accounts increased significantly to $2.4 million (from $1.1 million), representing 1.7% of net patient revenues compared to 1.0% in the prior year.
- Acquisitions: The Company acquired a 70% interest in a seven-clinic practice in May 2012 and two other clinics in the first quarter. Goodwill increased by approximately $6.4 million net of adjustments.
- Liquidity: Cash decreased by $1.2 million during the six-month period. The Company reduced its revolving credit facility balance by $3.5 million.
Guidance, Outlook, and Risks
Management Commentary: Management attributes revenue growth primarily to new clinics and acquisitions ("New Clinics"), which contributed 94,000 visits in the first six months. Mature clinic visits increased by 16,000. The Company plans to continue developing new clinics and evaluating acquisition opportunities.
Capital Resources: The Company maintains a $75.0 million revolving credit facility with $55.0 million available as of June 30, 2012. Management believes cash and credit availability are sufficient to fund operations, dividends, and future development through at least June 2013.
Risks and Contingencies:
- Medicare Reimbursement: The Company is subject to the "Therapy Cap" ($1,880 limit per beneficiary for PT/SLP and OT). The Middle Class Tax Relief and Job Creation Act of 2012 froze payment rates through December 31, 2012, but a manual medical review applies to patients exceeding $3,700 in expenditures starting October 1, 2012.
- Regulatory Environment: Operations are subject to extensive regulation, including potential changes in healthcare reform legislation and reimbursement rates.
- Concentration Risk: Dependence on third-party payors, including Medicare and Medicaid, for a significant portion of revenue.
- Internal Controls: Billing and cash collection controls are largely decentralized at clinic locations.
Investor Verification Checklist
- Medicare Policy Impact: Verify the specific impact of the $3,700 manual review threshold on high-volume patients and potential revenue adjustments.
- Bad Debt Trends: Investigate the drivers behind the doubling of the provision for doubtful accounts (from 1.0% to 1.7% of net patient revenues) and the adequacy of the allowance.
- Acquisition Integration: Assess the financial performance of the May 2012 seven-clinic acquisition and the two Q1 acquisitions to ensure they meet projected returns.
- Debt Covenants: Confirm continued compliance with the consolidated leverage ratio and fixed charge coverage ratio covenants under the $75M credit facility.
- Non-Controlling Interests: Review the trend of net income attributable to non-controlling interests, which decreased as the Company increased its ownership stake in partnerships.